15.83 USD
↗ 0.49 (3.19%)AT CLOSE (11:59 AM EDT)
Biohaven Ltd.
BHVNNYSE • USD
15.89
↗ 0.06 (0.40%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
15.89
↗ 0.06 (0.40%)
Market: CLOSED
Biohaven Ltd. (BHVN) trades at $15.83 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$15.71
High?$16.74
Low?$15.45
Prev. Close?$15.34
Volume?9.5M
Avg. Volume?3.6M
VWAP?$16.12
Rel. Volume?2.67x
Bid / Ask
Bid?$15.50 × 100
Ask?$15.91 × 100
Spread?$0.41
Midpoint?$15.71
Valuation & Ratios
Market Cap?2.4B
Shares Out?150.6M
Float?119.4M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?18.40
EPS?-$4.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Themes
Employees
274
Market Cap
2.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-09-23
Address
215 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-404-0410
NEW HAVEN, CT 06510
Phone: 203-404-0410
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.18Distress
Confidence?50%Low
Short InterestSqueeze Risk
Short % of Float?21.36%Squeeze Risk
Short Interest?25.5M
Days to Cover?8.1
Free Float119.4M
Avg Daily Volume3.2M
Settlement Date2026-06-15
Financial Health
Current Ratio?7.41Strong
Quick Ratio?7.41Strong
Cash Ratio?5.24Strong
Debt/Equity?1.87High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?18.40HIGH▾
Peers100
S&P8
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-500.1%WEAK▾
S&P3
ROA?-138.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-594486000
Enterprise Value?$2.4B
Fundamentals ratios updated end of day